Form 4: Oncology Institute Director Receives Stock Grant
Insider Transaction (Form 4)
Mark L Pacala, a Director of Oncology Institute, Inc., received 30,120 shares of common stock on July 27, 2026.
Summary
- Grant/award: acquired 30,120 Common Stock on July 27, 2026; holds 286,881 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Mark L Pacala — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-27 | Grant/award | Common Stock | 30,120 | — | — | 286,881 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-27 | Grant/award (30,120 shares) |
Keywords
insider transaction, Form 4, TOI, Oncology Institute, Inc., neutral, Mark L Pacala
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.